Quantification of cell-free DNA for the analysis of CD19-CAR-T cells during lymphoma treatment

Molecular Therapy — Methods & Clinical Development ◽

10.1016/j.omtm.2021.10.009 ◽

2021 ◽

Author(s):

Thomas Mika ◽

Julia Thomson ◽

Verena Nilius-Eliliwi ◽

Deepak Vangala ◽

Alexander Baraniskin ◽

...

Keyword(s):

T Cells ◽

Cell Free Dna ◽

Car T Cells ◽

Free Dna ◽

Lymphoma Treatment ◽

Download Full-text

Decision letter for "CXCR2‐modified CAR‐T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma"

10.1002/eji.201948457/v2/decision1 ◽

2020 ◽

Keyword(s):

Hepatocellular Carcinoma ◽

T Cells ◽

Car T Cells ◽

Download Full-text

Review for "CXCR2‐modified CAR‐T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma"

10.1002/eji.201948457/v1/review2 ◽

2019 ◽

Keyword(s):

Hepatocellular Carcinoma ◽

T Cells ◽

Car T Cells ◽

Download Full-text

Autologous Active IL-7 Receptor Co-expressing GD2-specific CAR T-cells

10.32388/ohva3w ◽

2020 ◽

Author(s):

Keyword(s):

T Cells ◽

Car T Cells ◽

Download Full-text

13 / Evaluation of immunosuppressive surface molecules, essential for resistance to CAR T-cells

10.26226/morressier.5b3b802db1b87b000eced9d4 ◽

2018 ◽

Author(s):

Titov Aleksei

Keyword(s):

T Cells ◽

Surface Molecules ◽

Car T Cells ◽

Download Full-text

Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies

Case Medical Research ◽

10.31525/ct1-nct03881774 ◽

2019 ◽

Author(s):

Keyword(s):

T Cells ◽

B Cell ◽

B Cell Malignancies ◽

Car T Cells ◽

Download Full-text

Modified Immune Cells (Autologous CAR T Cells) in Treating Patients With Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Case Medical Research ◽

10.31525/ct1-nct03907527 ◽

2019 ◽

Author(s):

Keyword(s):

T Cells ◽

Fallopian Tube ◽

Immune Cells ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Car T Cells ◽

Platinum Resistant ◽

Download Full-text

Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma

Case Medical Research ◽

10.31525/ct1-nct04119024 ◽

2019 ◽

Author(s):

Keyword(s):

T Cells ◽

Immune Cells ◽

Conditioning Regimen ◽

Car T Cells ◽

Download Full-text

A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and Lymphoma

Case Medical Research ◽

10.31525/ct1-nct04204161 ◽

2019 ◽

Author(s):

Keyword(s):

T Cells ◽

Clinical Study ◽

Car T Cells ◽

Download Full-text

Anti-CD19 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphomas

Case Medical Research ◽

10.31525/ct1-nct04196205 ◽

2019 ◽

Author(s):

Keyword(s):

T Cells ◽

Acute Lymphoblastic Leukemia ◽

Lymphoblastic Leukemia ◽

Car T Cells ◽

Download Full-text

Humanized CAR-T Cells of Anti-BCAM and Anti-CD19 Against Relapsed and Refractory Multiple Myeloma

Case Medical Research ◽

10.31525/ct1-nct04194931 ◽

2019 ◽

Author(s):

Keyword(s):

Multiple Myeloma ◽

T Cells ◽

Refractory Multiple Myeloma ◽

Car T Cells ◽

Download Full-text